NCT03332212: A Study That Looks at the Function of the Heart in Patients With Heart Failure Who Take Empagliflozin
- State
- Completed
- Phase
- Phase 3
- People
- 72 taking part
- Started
- 1 Mar 2018
- Primary completion
- 21 May 2020
- Arms
- Cohort A (Empagliflozin + Placebo), Cohort B (Empagliflozin + Placebo)
- Results
- Posted on the registry
- 6 Nov 2017: Trial registered
- 1 Mar 2018: Trial started
- 28 May 2020: Trial completed
- 18 Jun 2021: Trial results posted